China Pharma Holdings (CPHI) Other financing activities (2011 - 2012)
China Pharma Holdings' (CPHI) quarterly Other financing activities came in at $1.3 million in Q3 2012, down 73.96% YoY from $5.0 million in Q4 2011, and down 73.96% on a QoQ basis from $5.0 million in Q3 2011.
China Pharma Holdings (CPHI) Other financing activities (2011 - 2012) Analysis & Trends
China Pharma Holdings (CPHI) has 2 years of Other financing activities data on file, last reported at $1.3 million in Q3 2012.
- Quarterly Other financing activities fell 73.96% year-over-year to $1.3 million in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $6.3 million (changed N/A YoY) and the FY2010 annual result came in at $2.6 million, changed N/A from the prior year.
- Other financing activities retreated to $1.3 million in Q3 2012, from $5.0 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $5.0 million in Q3 2011 to a low of $1.3 million in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 1.30 Mn |
| Sep 30, 2012 | 1.30 Mn |
| Sep 30, 2011 | 4.97 Mn |
| Sep 30, 2011 | 4.97 Mn |